Erasmus University Medical Center competitive analysis

Explore Erasmus University Medical Center's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 3, 2026
Patent NumberPublication DateTitleTotal Oppositions
Mar 22, 2023Soluble "Heavy-Chain Only" Antibodies3
Aug 20, 2014Binding Molecules3

Latest PTAB cases involving Erasmus University Medical Center

Discover the latest PTAB cases involving Erasmus University Medical Center, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Erasmus University Medical Center with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 3, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
ERASMUS UNIVERSITY MEDICAL CENTER ROTTERDAM - 6 - -
ABLYNX158 - -
CRESCENDO BIOLOGICS12 - -
REGENERON PHARMACEUTICALS55145932